A Real-World Experience With the Supera Interwoven Nitinol Stent in Femoropopliteal Arteries

Abstract

In this heterogeneous group that included long and complex atheromatous femoropopliteal lesions, the Supera stent achieved excellent clinical and patency results at 1 year. Further improvement may be achieved through careful patient selection and the avoidance of deployment pitfalls.